Pre-transjugular-intrahepatic-portosystemic-shunt measurement of hepatic venous pressure gradient and its clinical application: A comparison study

Figure 3 Comparison of transplant-free survival rates between the patients with endoscopic therapy+non-selective β-blockers and covered transjugular intrahepatic portosystemic shunts during the whole follow-up period. A: The total cohort; B: Patients on low-hepatic venous pressure gradient (HVPG) tier; C: Patients on high-HVPG tier; D: Patients with viral cirrhosis or alcoholic cirrhosis; E: Patients with viral cirrhosis or alcoholic cirrhosis on low-HVPG tier; F: Patients with viral cirrhosis or alcoholic cirrhosis on high-HVPG tier; TIPS: Transjugular intrahepatic portosystemic shunt; NSBBs: Non-selective β-blockers.